"The Mission of HOA is to provide the highest level of quality care in a healing environment for the mind, body and spirit of patients dealing with cancer and blood disorders. Our goal is to offer the highest level, state of the art technology and treatments, while meeting the emotional needs of our patients and their families."

During the past decade, CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C. conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 61 clinical trials were completed, i.e. on average, 169.4% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 14 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C." #1 sponsor was "Alliance for Clinical Trials in Oncology" with 115 trials, followed by "Radiation Therapy Oncology Group" with 34 trials sponsored, "National Cancer Institute (NCI)" with 31 trials sponsored, "SWOG Cancer Research Network" with 21 trials sponsored and "NSABP Foundation Inc" with 21 trials sponsored. Other sponsors include 41 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C." #1 collaborator was "National Cancer Institute (NCI)" with 217 trials as a collaborator, "Cancer and Leukemia Group B" with 21 trials as a collaborator, "SWOG Cancer Research Network" with 17 trials as a collaborator, "Eastern Cooperative Oncology Group" with 12 trials as a collaborator and "NCIC Clinical Trials Group" with 11 trials as a collaborator. Other collaborators include 53 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C." are "Breast Cancer" (42 trials), "Lung Cancer" (34 trials), "Colorectal Cancer" (18 trials), "Prostate Cancer" (18 trials) and "Leukemia" (17 trials). Many other conditions were trialed in "CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C." in a lesser frequency.

Most popular intervention types in "CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C." are "Drug" (198 trials), "Other" (71 trials), "Biological" (66 trials), "Radiation" (59 trials) and "Procedure" (51 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (47 trials), "Quality-of-Life Assessment" (25 trials), "paclitaxel" (25 trials), "cisplatin" (22 trials) and "carboplatin" (20 trials). Other intervention names were less common.

The vast majority of trials in "CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C." are 206 trials for "All" genders, 40 trials for "Female" genders and 17 trials for "Male" genders.

Currently, there are NaN active trials in "CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.". undefined are not yet recruiting, 20 are recruiting, 31 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 185 completed trials in CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., 1 suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., 16 "Phase 1" clinical trials were conducted, 101 "Phase 2" clinical trials and 128 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".

CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C. has several departments that took part in Clinical trials: "Hematology Oncology Associates of Central New York-East Syracuse" - 109 trials, "Hematology Oncology Associates of Central New York-Auburn" - 50 trials